Voting is now open for the Genesis BioNewsRound Award 2023!

We are delighted to announce the following companies as finalists in our Genesis BioNewsRound Award 2023. Voting is now open for everyone, please click on the voting button below.

• Astex Pharmaceuticals/MSD

Astex expands drug discovery collaboration with MSD

• Etcembly

Etcembly reveals world’s first AI generative bispecific T cell engager with picomolar affinity

• Maxion Therapeutics

Maxion Therapeutics’ $16 million Series A to drive antibody development for previously untreatable ion channel and GPCR-driven diseases

• NRG Therapeutics

NRG Therapeutics Awarded Second $500K Grant from The Michael J. Fox Foundation to Further Progress Parkinson’s Programme

• PrecisionLife/LifeArc

Precision Life and LifeArc announce strategic MND/ALS partnership

• Quadram Institute/Oxford Nanopore

The World Health Organization supports the use of targeted sequencing to detect drug resistance in tuberculosis

Voting will close at 14.00 (GMT) on 7 December 2023

The winner will be announced during the afternoon of the Genesis conference on 7 December 2023.